Natac Natural Ingredients Sa · BME:NAT
Natac Natural Ingredients Sa — Investor Presentation (2025)
27 slides from Natac Natural Ingredients Sa's investor presentation, 2025
Slide 1: 9
9
Slide 2: Who are we?
Who are we? We are a consolidated business group in the natural ingredients market, specialized in the research, development, Our differentiation is based on our ability to create innovative manufacturing, and commercialization of plant extracts and products tailored to the specific Omega-3 oils for
Slide 3: Evolution
Evolution 2024 2018 2016 Start-up of the 2012 2014 2020 2022 As Somozas plant and beginning of the Olive extract Opening of Launch of Natac ranks among the Construction production and factory commercia products with 65 most of a new Opening of commercialization of l innovative SMEs in Europe commerc
Slide 4: International presence
International presence The strategic location of our production, R&D, and Quality units EUROPE USA SPAIN 73.18% in Spain guarantees the highest 8.76% 8.89% quality standards and compliance with European regulations. ASIA 6.99% ASIA 23.38% 91% Exports 0.37% LATAM 1.80% Percentages based on ordinary p
Slide 5: What do we do?
What do we do? NUTRACEUTICAL PHARMACEUTICAL FEED FOOD OMEGA3 SERVICES Rendered 34% 50% 11% 2% 2% 1% We work closely with We provide We offer a wide variety We help our clients At our Omega-3 plant in We provide research and companies in this sector in pharmaceutical active of ingredients and develop
Slide 6: Mission Vision Values
Mission Vision Values To transfer scientific knowledge To be a global benchmark company in We are a committed team to sustainable and industrially viable improving quality of life by applying focused on the client, driven by a projects that create value and improve the benefits of nature through sci
Slide 7: ESG - Environmental, Social and Governance
E S G - Environmental, Social and Governance RELIABLE PARTNER THERE IS NO PLANET B PERSONS We aim to be a trusted partner for our customers, Our clear and firm objective is to reduce our At Natac we are firmly committed to our team and producing ingredients while ensuring supply, quality, environmen
Slide 8: Market
Market 9EUROPE .3% 67.23% The natural extracts NATURAL EXTRACTS OMEGA-3 and Omega-3 sectors are expanding significantly, with notable growth in recent years. Revenue 2030 CAGR 2020-2030 Revenue 2030 CAGR 2020-2030 118.6B% 118.6B% 118.6B% • A shift in consumer habits toward more 50B Revenue 8% Revenu
Slide 9: Market
Market Global Plant Extract Market Trend vs NATAC Global Omega-3 Market Trend vs NATAC 300 100,00 90,00 250 80,00 200 70,00 60,00 150 50,00 40,00 100 30,00 50 20,00 10,00 0 0,00 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 Cervicom Technavi
Slide 10: Value Chain
Value Chain R&D Capacity Sustainability and Production Quality Control Efficiency Vertical raw material capacity Business Model sourcing Natac’s team of Natac has designed a experts carries out highly efficient Natac has the most modern The company has exhaustive research to business model both It c
Slide 11: Business Model
Business Model A sustainable business model ensuring the optimal utilization Resources of resources, transforming them into value-added ingredients with a positive impact on people’s health Bioenergy and bio-fertilisers Agri-food industry Benefits of the model: Leader in natural ingredients enhancin
Slide 12: Board of Directors, Executive and Management Committee
BOARD OF DIRECTORS EXECUTIVE AND MANAGEMENT COMMITTEE Aldabi Inversiones, S.L.U., represented by D. Antonio Ángel Delgado Romero, D. Antonio Delgado Romero, Chief Executive Officer and Co-founder. (*) Chairman. D. José Carlos Quintela Fernández, Vicepresident and Co-founder. Idoasis 2002, S.L., repr
Slide 13: Analyst coverage
Analyst coverage Analysts’ reports on the company are available on the Natac website, in the Investors section. Analyst: Analyst: Analysts: César Sánchez Grande. David López. Daniel Gandoy y Alfredo Echevarría. Latest target price: Latest target price: 0.84€ / share 0.92€ / share View Report View Re
Slide 14: Why invest in Natac?
Why invest in Natac? High fragmentation Consolidation Sectors with strong Outstanding in the Growth Constant ESG and entry barriers annual growth performance pharmaceutical in Omega-3 innovation commitment sector The group operates in Natac, a leader in the The plant extract sector Agreement with a
Slide 15: Evolution of the business model in 2025
Evolution of the business model in 2025 % Distribution of net revenue by business % Distribution of net turnover by segments 2025 geography 2025 GEOGRAPHIC REGION 2025 2024 %VAR Product for Sale SPAIN 4,197,073.89 2,908,281.52 44.31% EUROPE (*) 34,568,755.65 24,096,284.78 43.46% ASIA 3,302,937.69 4,
Slide 16: Business evolution by sector and plant extract market
Business evolution by sector and plant extract market Revenue by Sector Revenue by Market 40.000.000 30.000.000 35.000.000 25.000.000 30.000.000 20.000.000 25.000.000 15.000.000 20.000.000 10.000.000 15.000.000 10.000.000 5.000.000 5.000.000 0 2018 2019 2020 2021 2022 2023 2024 2025 0 2018 2019 2020
Slide 17: Evolution of revenue and normalized EBITDA
Evolution of revenue and normalized EBITDA Net revenue and EBITDA amount EBITDA and % EBITDA growth 47.825.205,51 24.500.000 46.000.000 25 900% 23.016.832,87 23,02 804,18% 22.000.000 800% 41.000.000 35.851.005,34 20 36.000.000 19.500.000 700% 31.000.000 17.000.000 600% 26.554.975,08 15 13,82 14.500.
Slide 18: Sales/Employees evolution
Sales/Employees evolution Sales / Number of employees evolution 50.000.000 45.000.000 225 40.000.000 35.000.000 181 171 175 30.000.000 152 25.000.000 133 125 20.000.000 15.000.000 90 84 10.000.000 75 63 5.000.000 36 0 25 2018 2019 2020 2021 2022 2023 2024 2025 Net Turnover Number of employees 18
Slide 19: Evolution of plant extract revenue
Evolution of plant extract revenue Evolution of Natac sales growth vs Plant Extract sector 700% 600% 500% 400% 300% 200% 100% 0% 2018 2019 2020 2021 2022 2023 2024 2025 NATAC SALES GROWTH SECTOR AVERAGE 19
Slide 20: Forecast compliance evolution
Forecast compliance evolution COMMENTS The Group achieved revenue of €47.83 million in 2025, representing 96% of the MAIN FINANCIAL KPIs COMPLIANCE revenue target. The deviation is mainly explained by delays in Omega-3 2025E 2025R ((Figures in millions of euros) RATE sales, as not all required certi
Slide 21: Net Financial Debt / Normalized EBITDA - 2025
Net Financial Debt / Normalized EBITDA - 2025 Financial Debt Composition Consolidated No Convertible 2025 Consolidated excluding Grants Loans or Grants Consolidated Consolidated excluding Convertible Total Debt 84,454,679.70 73.563.435,69 62,914,716.57 excluding Grants Loans and Grants €73.56 €62.91
Slide 22: Main Financial Figures
Main Financial Figures Total revenue Normalized EBITDA 2021 2022 2023 2024 2025 60,00 25,00 23,02 Total Revenue 20359 22,409 26555 35,851 47,825 50,00 47,83 20,00 Normalized EBITDA 8021 7621 9412 13,816 23,017 NORMALIZED EBITDA 40,00 35,85 39.40% 34.01% 35.44% 38.54% 48.13% 13,82 MARGIN 15,00 Total
Slide 23: Plan 2026-2027
Plan 2026-2027 ESTIMATES 2026 Total revenue € >68 M 80,00 Normalized EBITDA* € >26 M 70,00 60,00 23,02 ANNUAL GROWTH 2024 – 2025 50,00 13,82 Total revenue 33.40% 40,00 Normalized EBITDA* 66.59% 30,00 9,41 8,02 7,62 47,83 20,00 7,25 4,33 35,85 YEAR-OVER-YEAR GROWTH 2020 – 2025 26,55 10,00 20,36 22,41
Slide 24: Business plan
Business plan 1 2 3 4 5 Growth and Agreement with American Entry into the API Expansion of the Hervás Increased revenue from consolidation in the pharmaceutical company: production market factory - SustaiNext new markets Omega-3 market increased volume of operations Omega-3 allows the Group to A US
Slide 25: Headquarters
Headquarters EUROPE PRODUCTION CENTERS AMERICA APAC Headquarters Commercial Office Commercial Office Av. Rita Levi Montalcini, 14 Las Cañadas Industrial Estate, 10700 3 Shenton Way, #08-04 2825 E Cottonwood 28906 – Getafe Hervás, Cáceres, Spain Pkwy Suite 500 Shenton House Madrid, Spain Salt Lake Ci
Slide 26: Glossary of terms
Glossary of terms ▪ TOTAL AMOUNT OF TURNOVER ▪ NFD Revenue – product sales: revenue derived from the marketing of natural plant extracts and Acronym for Net Financial Debt, which indicates the level of financial debt of the Omega-3. consolidated Natac Natural Ingredients Group. This is the sum of al
Slide 27: Thank you!
Neo Thank you!
Natac Natural Ingredients — Investor Presentation (2025) on 6ix